Exploring the safety and immunogenicity of the VLA15 vaccine among healthy or high-risk population: a systematic review and meta-analysis of randomized controlled trials.

Ther Adv Vaccines Immunother · 2025 · PMC12575933 · PMID 41179932

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp < 0.00001actually significant

The test for overall effect showed a highly significant result ( Z = 4.74; p < 0.00001), indicating that fever was significantly more likely in individuals receiving VLA15 than those receiving placebo.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.